Skip to main content

Sigilon Therapeutics, Inc.

SGTXDelisted Aug 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001821323

Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
16
Q2 2023, −16 vs. previous quarter
13F value
$26.6M
Reported value at the end of Q2 2023
Superinvestors holding
0
At the end of Q2 2023

From SEC filings, in USD.

Revenue, FY2022
$12.9M
+34.8% year over year
Net income, FY2022
-$43.6M
No comparable prior period
Free cash flow, FY2022
-$52.0M
No comparable prior period
Revenue, Q2 FY2023
$5.90M
+104.6% year over year

Revenue flow, FY2022

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2022: $43.6M (336.5% of revenue).

Superinvestors holding SGTX, Q2 2023

Go to the superinvestors tab

No superinvestor reported holding SGTX at the end of Q2 2023.

Latest insider trades

See all insider trades

Open-market purchases and sales by Sigilon Therapeutics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 14, 2023 (view filing)4:30 PM ETAug 113 daysEli Lilly & Co and 1 other10% OwnerPPurchase+1.72M$14.92+$25.6MNew position100 after
Jul 2, 2021 (view filing)Jul 11 dayRuffolo Robert RDirectorSSale−6.75K$10.36−$69.9K−100.0%0 after

Top 10 13F holders, Q2 2023

See all 16 holders

The largest institutional positions in Sigilon Therapeutics, Inc. at the end of Q2 2023; share changes are against Q1 2023.

Institutions holding SGTX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Flagship Pioneering Inc.797,720$18.0M0.80%00.0%UnchangedConverted for a 1-for-13 split
Canada Pension Plan Investment Board114,244$2.57M0.00%00.0%UnchangedConverted for a 1-for-13 split
FMR LLC78,796$1.77M0.00%−2,327−2.9%ReducedConverted for a 1-for-13 split
HarbourVest Partners LLC56,979$1.28M0.36%00.0%UnchangedConverted for a 1-for-13 split
Yakira Capital Management, Inc.39,746$894.7K0.24%+39,746New
State of Wisconsin Investment Board39,202$882.4K0.00%00.0%UnchangedConverted for a 1-for-13 split
Vanguard Group Inc23,144$521.0K0.00%00.0%UnchangedConverted for a 1-for-13 split
CSS LLC13,292$299.2K0.02%+13,292New
Bridgeway Capital Management, LLC9,615$216.4K0.01%00.0%UnchangedConverted for a 1-for-13 split
Morgan Stanley6,418$144.5K0.00%−12,569−66.2%ReducedConverted for a 1-for-13 split